Periodontal Disease Mechanisms and Biomarkers

Periodontal disease encompasses a continuum from reversible gingivitis to irreversible periodontitis, driven by complex interactions between a dysbiotic subgingival biofilm and the host immune response. Bacterial products such as lipopolysaccharide provoke an innate inflammatory cascade, recruiting neutrophils and macrophages that release reactive oxygen species and pro-inflammatory cytokines (for example interleukin-1β and tumour necrosis factor-α). Chronic inflammation disrupts homeostasis in the periodontal ligament and alveolar bone, with hypoxic microenvironments stabilising hypoxia-inducible factor-1α and promoting vascular endothelial growth factor-mediated angiogenesis. At the osseous interface, the receptor activator of nuclear factor-κB ligand (RANKL) and its decoy receptor osteoprotegerin (OPG) regulate osteoclast differentiation and activity, tipping the balance towards bone resorption in active disease. Biomarker research has moved beyond clinical probing to include salivary and crevicular fluid profiles of RANKL/OPG ratios, host-derived enzymes (for example matrix metalloproteinases), and novel imaging-based indices of tissue perfusion. Integration of mechanistic insights with non-invasive diagnostics offers the prospect of early detection, patient stratification and personalised therapeutic monitoring, underscoring the global significance of managing periodontal health as a component of systemic wellness.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Periodontal Disease Mechanisms and Biomarkers publication trend

The graph below shows the total number of articles in periodontal disease mechanisms and biomarkers across all publications each year (not limited to Nature Index journals).

Technical terms

Biofilm: A structured microbial community adherent to the tooth surface, embedded in a self-produced extracellular matrix.

Hypoxia: A condition of reduced oxygen tension in tissues, leading to stabilisation of hypoxia-inducible factors and altered gene expression.

RANKL: Receptor activator of nuclear factor-κB ligand, a cytokine essential for osteoclast differentiation and activation.

Osteoprotegerin (OPG): A soluble decoy receptor that binds RANKL, inhibiting osteoclastogenesis and bone resorption.

Hemodynamic Spectral Indices (HSIs): Quantitative optical metrics derived from tissue reflectance spectra that indicate blood oxygenation and volume.

References

1. Non-invasive assessment of periodontal inflammation by continuum-removal hemodynamic spectral indices. European Journal of Medical Research (2024).
2. Vascular Changes and Hypoxia in Periodontal Disease as a Link to Systemic Complications. Pathogens (2021).
3. Impact of periodontal treatment on the RANKL/OPG ratio in crevicular fluid. PLOS ONE (2020).